ONTX - Onconova Therapeutics Inc
Close
0.9953
-0.005 -0.472%
Share volume: 1,281,870
Last Updated: Tue 02 Apr 2024 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$1.00
0.00
-0.47%
Summary score
48%
Profitability
53%
Dept financing
40%
Liquidity
24%
Performance
52%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
82.71%
Return on assets
-45.28%
Return on sales
0%
Return on invested capital
61.09%
Total debt ratio
115.12%
Debt ratio change over timeo
1.35%
Current Ratio
2.03%
Quick Ratio
0%
Cash Position Ratio
1.77%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.19%
Return on assets
-37.77%
Return on sales
0%
Return on invested capital
72.73%
Total debt ratio
82.43%
Debt ratio change over timeo
0.7%
Current Ratio
2.84%
Quick Ratio
0%
Cash Position Ratio
2.73%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-47.3%
Return on assets
-26.03%
Return on sales
0%
Return on invested capital
86.58%
Total debt ratio
44.56%
Debt ratio change over time
-0.41%
Current Ratio
3.2%
Quick Ratio
0%
Cash Position Ratio
3.11%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
3.2%
Return on assets
-194.44%
Return on sales
0%
Return on invested capital
29.78%
Total debt ratio
135.24%
Debt ratio change over time
1.35%
Current Ratio
2.94%
Quick Ratio
0%
Cash Position Ratio
2.43%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ONTX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 82.71% | 0% | 0% | 29.06% |
| Return on assets | -45.28% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 61.09% | 0% | 0% | 47.78% |
| Profitability | 75% | 0% | 25% | 28% |
| Total debt ratio | 115.12% | 0% | 0% | 183.15% |
| Debt ratio change over time | 1.35% | 0% | 0% | 19.02% |
| Dept financing | 17% | 0% | 0% | 50% |
| Current Ratio | 2.84% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.73% | 0% | 0% | 5.68% |
| Liquididy | 24% | 0% | 0% | 75% |
| Short-term ratios | ONTX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -11.19% | 0% | 0% | -16.12% |
| Return on assets | -37.77% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 72.73% | 0% | 0% | 96.56% |
| Profitability | 44% | 0% | 50% | 25% |
| Total debt ratio | 82.43% | 0% | 0% | 79.61% |
| Debt ratio change over time | 0.7% | 0% | 0% | 0.09% |
| Dept financing | 50% | 0% | 0% | 27% |
| Current Ratio | 2.84% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.73% | 0% | 0% | 5.68% |
| Liquididy | 24% | 0% | 0% | 75% |